# ClinicalTrials.gov record NCT03596905

> PeptideScanner retained ClinicalTrials.gov record NCT03596905 at 2026-07-30T18:18:33.534Z. Its registry update date was 2025-12-31, and PeptideScanner's reviewed identity mapping was plecanatide.

- Evidence object: `story:clinicaltrials-gov-nct03596905-plecanatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2025-12-31
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03596905-plecanatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03596905-plecanatide-v1.json
- Content SHA-256: `b6531d26228e9621b4862003c649d8f13c93e01280752c45bae7b0dfad692ff8`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT03596905 ([`ctg-observation-nct03596905-2025-12-31-98105c156174`](#source-ctg-observation-nct03596905-2025-12-31-98105c156174))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03596905 at 2026-07-30T18:18:33.534Z. Its registry update date was 2025-12-31, and PeptideScanner's reviewed identity mapping was plecanatide. ([`ctg-observation-nct03596905-2025-12-31-98105c156174`](#source-ctg-observation-nct03596905-2025-12-31-98105c156174))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03596905 at 2026-07-30T18:18:33.534Z. Its registry update date was 2025-12-31, and PeptideScanner's reviewed identity mapping was plecanatide. ([`ctg-observation-nct03596905-2025-12-31-98105c156174`](#source-ctg-observation-nct03596905-2025-12-31-98105c156174))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03596905-2025-12-31-98105c156174`](#source-ctg-observation-nct03596905-2025-12-31-98105c156174))

## Sources

<a id="source-ctg-observation-nct03596905-2025-12-31-98105c156174"></a>
- **ClinicalTrials.gov record NCT03596905 · retained source version 2025-12-31:98105c156174c311e3f4c76c575d55aa560df2d8016c1dab83d508b44b89f5d7** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03596905) (`ctg-observation-nct03596905-2025-12-31-98105c156174`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03596905." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03596905-plecanatide-v1.json SHA-256: b6531d26228e9621b4862003c649d8f13c93e01280752c45bae7b0dfad692ff8.